Clinical Trial Update: Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia [Phase 3]

View source ↗

Summary

This document reports an update on a Phase 3 clinical study of DA-007 for chemotherapy-induced alopecia, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Alopecia

Drugs mentioned

• DA-007

Snippet

Sponsor: Applied Biology, Inc. | Conditions: Chemotherapy Induced Alopecia, Chemotherapy Side Effects | Phase 3 | Status: NOT_YET_RECRUITING